Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alto Neuroscience (ANRO) Shares Outstanding (2023 - 2026)

Alto Neuroscience has reported Shares Outstanding over the past 4 years, most recently at $35.1 million for Q1 2026.

  • Quarterly results put Shares Outstanding at $35.1 million for Q1 2026, up 29.48% from a year ago — trailing twelve months through Mar 2026 was $35.1 million (up 29.48% YoY), and the annual figure for FY2025 was $31.9 million, up 18.29%.
  • Shares Outstanding reached $35.1 million in Q1 2026 per ANRO's latest filing, up from $31.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $35.1 million in Q1 2026 and bottomed at $3.8 million in Q1 2023.
  • Median Shares Outstanding over the past 4 years was $27.0 million (2024), compared with a mean of $20.9 million.
  • The largest annual shift saw Shares Outstanding skyrocketed 614.24% in 2024 before it rose 0.45% in 2025.
  • Over 4 years, Shares Outstanding stood at $3.8 million in 2023, then soared by 604.25% to $27.0 million in 2024, then grew by 18.29% to $31.9 million in 2025, then rose by 9.8% to $35.1 million in 2026.
  • Business Quant data shows Shares Outstanding for ANRO at $35.1 million in Q1 2026, $31.9 million in Q4 2025, and $27.2 million in Q3 2025.